Investor Presentaiton
Study of the efficacy and safety of topical
Ivermectine and Iota-carrageenan
Positive data on the prophylaxis of COVID-19 for health care personnel
Group
Study
participants
Iota-carrageenan +
131
Ivermectin
Standard of care
98
Incidence of
SARS-COV-2
(PCR)
0
11
p < 0.0001
marino
med
Intervention
Iota + Ivermectin group
topical medication, iota-
carrageenan and Ivermectin,
5 times a day. PPEs used as
suggested by OMS.
Control group
PPES used as suggested
by OMS
Clinical trial registration
and identifier number
NCT04425850
...valuable tool, to optimize the protection of the people most exposed to
contracting the disease, such as health care personnel
Source: Carvallo, Héctor E.; Contreras, Veronica, Htal. Interzonal A. A. Eurnekian, Buenos Aires, Argentina
7View entire presentation